2022 AMI Online Salon
Totus Covalent MOA
Project Detail
- Entrant Name: David Ehlert
- Client: Totus Medicines
- Copyright: Totus Medicines, 2021
- Medium/software used: C4D, After Effects
- Final presentation format: Website video
- Primary Audience: Investors, potential partners, future recruits
Project Description
Although researchers have discovered hundreds of drug targets to treat disease, 90% of these targets are considered “undruggable” and therefore untreatable. Covalent therapeutics are some of the most impactful in society yet make up only 2% of the market because, in the past, they have primarily been identified accidentally. The animation showcases that covalent bonding used in conjunction with Totus Medicines’ proprietary machine learning technology platform for high-throughput drug discovery converts genetic discoveries into real drugs, making more diseases treatable.The animation presents on the client’s website and social media platforms. Therefore, communication challenges included telling the complexity of their story while connecting with a diverse audience to create an impact that is accessible, relatable, and understandable. We used a storytelling approach that highlighted the problem of seemingly untreatable diseases, the opportunity in the platform, and the shared purpose of addressing the unmet medical need. We used visuals that enhanced the sense of moving from the legacy in historic covalent medicines to the future of novel applications to reinforce the narrative.
